Literature DB >> 5673568

Antitumor effect of intracutaneous injection of bacterial lipopolysaccharide.

D Mizuno, O Yoshioka, M Akamatu, T Kataoka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5673568

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  11 in total

Review 1.  Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.

Authors:  Jason R Baird; Arta M Monjazeb; Omid Shah; Heather McGee; William J Murphy; Marka R Crittenden; Michael J Gough
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-19       Impact factor: 7.038

2.  Influence of PSK (Krestin) on resistance to infection of Pseudomonas aeruginosa in tumor-bearing mice.

Authors:  T Ando; I Motokawa; K Sakurai; Y Ohmura; T Fujii; K Matsunaga; C Yoshikumi; K Nomoto
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Haemorrhagic tumour necrosis following endotoxin administration. I. Communication: morphological investigation on endotoxin-induced necrosis of the methylcholanthrene (Meth A) tumour in the mouse.

Authors:  N Freudenberg; K Joh; O Westphal; C Mittermayer; M A Freudenberg; C Galanos
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

4.  Therapeutic ratio of mono or combination bacterial lipopolysaccharide therapy in methylnitrosourea-induced rat mammary carcinoma.

Authors:  M R Berger; E Petru; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Antitumor effects of bacterial lipopolysaccharide and tumor necrosis factor in mice.

Authors:  N Moriya; H Miwa; K Orita
Journal:  Jpn J Surg       Date:  1984-03

6.  Macrophage activation by monosaccharide precursors of Escherichia coli lipid A.

Authors:  M Nishijima; F Amano; Y Akamatsu; K Akagawa; T Tokunaga; C R Raetz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Trial Watch: Experimental Toll-like receptor agonists for cancer therapy.

Authors:  Lorenzo Galluzzi; Erika Vacchelli; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

Review 8.  Therapeutic cancer vaccines: past, present, and future.

Authors:  Chunqing Guo; Masoud H Manjili; John R Subjeck; Devanand Sarkar; Paul B Fisher; Xiang-Yang Wang
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

9.  Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis.

Authors:  M Ohnishi; S Kimura; M Yamazaki; H Oshima; D I Mizuno; S Abe; H Yamaguchi
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

10.  Cellular uptake of exogenous calcineurin B is dependent on TLR4/MD2/CD14 complexes, and CnB is an endogenous ligand of TLR4.

Authors:  Jinju Yang; Nannan Qin; Hongwei Zhang; Rui Yang; Benqiong Xiang; Qun Wei
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.